Individualizing tapering antipsychotic schemes considering D2 blockade dynamics.

Costardi, Carlos G; Gadelha, Ary; Bressan, Rodrigo A

Costardi, Carlos G; Gadelha, Ary; Bressan, Rodrigo A.

Affiliation

Costardi CG; Laboratório Interdisciplinar de Neurociências Clínicas (LiNC), Departamento de Psiquiatria, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Gadelha A; Programa de Esquizofrenia (PROESQ), Departamento de Psiquiatria, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Bressan RA; Instituto Ame Sua Mente, São Paulo, Brazil.

J Psychopharmacol ; 35(9): 1161-1162, 2021 Sep.

Article in En | MEDLINE | ID: mdl-34313143

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Drug Tapering Type of study: Guideline Limits: Humans Language: En Journal: J Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2021 Document type: Article Affiliation country: Brasil

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google